Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ferry

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Inflammatory Bowel Diseases|January 1, 2005
CDP571, a humanized anti-tumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's diseasePetar Mamula, Stanley A Cohen, George D Ferry, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1986
Total parenteral nutrition-related cholestasis in infantsR L Bell, G D Ferry, E O Smith, et al.
Journal of Hazardous Materials|March 1, 2022
KI and TEDA influences towards the retention of radiotoxic CH<sub>3</sub>I by activated carbonsH Lin, M Chebbi, C Monsanglant-Louvet, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 27, 2007
Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux diseaseDiego M Diaz, Harland S Winter, Richard B Colletti, et al.
Cancer Treatment Reviews|February 12, 2016
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancerD A Fennell, Y Summers, J Cadranel, et al.
Clinical Endocrinology|February 1, 1994
ACTH precursors characterize the ectopic ACTH syndromeP M Stewart, S Gibson, S R Crosby, et al.
British Journal of Cancer|August 2, 2006
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinomaS Falk, A Anthoney, M Eatock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 1, 1992
Relationship of common laboratory parameters to the activity of Crohn's disease in childrenJ S Hyams, F Mandel, G D Ferry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer StudyJ A Ajani, M Buyse, M Lichinitser, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Inflammatory Bowel Diseases|January 1, 2005
CDP571, a humanized anti-tumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's diseasePetar Mamula, Stanley A Cohen, George D Ferry, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1986
Total parenteral nutrition-related cholestasis in infantsR L Bell, G D Ferry, E O Smith, et al.
Journal of Hazardous Materials|March 1, 2022
KI and TEDA influences towards the retention of radiotoxic CH<sub>3</sub>I by activated carbonsH Lin, M Chebbi, C Monsanglant-Louvet, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 27, 2007
Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux diseaseDiego M Diaz, Harland S Winter, Richard B Colletti, et al.
Cancer Treatment Reviews|February 12, 2016
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancerD A Fennell, Y Summers, J Cadranel, et al.
Clinical Endocrinology|February 1, 1994
ACTH precursors characterize the ectopic ACTH syndromeP M Stewart, S Gibson, S R Crosby, et al.
British Journal of Cancer|August 2, 2006
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinomaS Falk, A Anthoney, M Eatock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 1, 1992
Relationship of common laboratory parameters to the activity of Crohn's disease in childrenJ S Hyams, F Mandel, G D Ferry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer StudyJ A Ajani, M Buyse, M Lichinitser, et al.
Pageof 17